Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-21-039245
Date:2021-06-02
Issuer: PMV PHARMACEUTICALS, INC. (PMVP)
Original Submission Date:

Reporting Person:

THOMPSON PETER A.
C/O PMV PHARMACEUTICALS, INC.
8 CLARKE DRIVE, SUITE 3 CRANBURY, NJ 08512

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 32.29 2022-06-02 deemed execution date A 16,333 (a) 2031-06-01 common stock 16,333 $32.29 16,333 direct
Footnotes
IDfootnote
f1 shares subject to the option vest on the earlier of (i) june 2, 2022 or (ii) the day prior to the date of the issuer's next annual meeting of stockholders.
f2 pursuant to an agreement with orbimed advisors llc and orbimed capital gp v llc, the reporting person is obligated to transfer any securities issued under any such stock options or other awards, or the economic benefit thereof, to orbimed advisors llc and orbimed capital gp v llc, which will in turn ensure that such securities or economic benefits are provided to orbimed private investments v, lp.

Elevate your investments